IsoPlexis Corp Analysis

IsoPlexis Corp holds a debt-to-equity ratio of 0.572. With a high degree of financial leverage come high-interest payments, which usually reduce IsoPlexis Corp's Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

IsoPlexis Corp's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. IsoPlexis Corp's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps IsoPlexis Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect IsoPlexis Corp's stakeholders.
For most companies, including IsoPlexis Corp, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for IsoPlexis Corp, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, IsoPlexis Corp's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that IsoPlexis Corp's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which IsoPlexis Corp is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of IsoPlexis Corp to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, IsoPlexis Corp is said to be less leveraged. If creditors hold a majority of IsoPlexis Corp's assets, the Company is said to be highly leveraged.
IsoPlexis Corp is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of IsoPlexis Corp delisted stock analysis is to determine its intrinsic value, which is an estimate of what IsoPlexis Corp is worth, separate from its market price. There are two main types of IsoPlexis Corp's stock analysis: fundamental analysis and technical analysis.
The IsoPlexis Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. IsoPlexis Corp is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. IsoPlexis Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

IsoPlexis Stock Analysis Notes

About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. IsoPlexis Corp recorded a loss per share of 2.63. The entity had not issued any dividends in recent years. IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company was incorporated in 2013 and is based in Branford, Connecticut. Isoplexis Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 459 people. To learn more about IsoPlexis Corp call Sean Mackay at 203 208 4111 or check out https://isoplexis.com.

IsoPlexis Corp Investment Alerts

IsoPlexis Corp is not yet fully synchronised with the market data
IsoPlexis Corp has some characteristics of a very speculative penny stock
IsoPlexis Corp has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 16.76 K. Reported Net Loss for the year was (106 K) with loss before taxes, overhead, and interest of (925 K).
IsoPlexis Corp has about 71.61 M in cash with (96.64 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.82.
Over 77.0% of the company shares are owned by institutional investors

IsoPlexis Corp Upcoming and Recent Events

Earnings reports are used by IsoPlexis Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
10th of May 2023
Upcoming Quarterly Report
View
9th of August 2023
Next Financial Report
View
31st of March 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
31st of December 2022
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

IsoPlexis Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 32.91 M.

IsoPlexis Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IsoPlexis Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on IsoPlexis Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IsoPlexis Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

IsoPlexis Corp Outstanding Bonds

IsoPlexis Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. IsoPlexis Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IsoPlexis bonds can be classified according to their maturity, which is the date when IsoPlexis Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

IsoPlexis Corp Debt to Cash Allocation

As IsoPlexis Corp follows its natural business cycle, the capital allocation decisions will not magically go away. IsoPlexis Corp's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
IsoPlexis Corp has 46.35 M in debt with debt to equity (D/E) ratio of 0.57, which is OK given its current industry classification. IsoPlexis Corp has a current ratio of 10.0, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for IsoPlexis to invest in growth at high rates of return.

IsoPlexis Corp Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the IsoPlexis Corp's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of IsoPlexis Corp, which in turn will lower the firm's financial flexibility.

IsoPlexis Corp Corporate Bonds Issued

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding IsoPlexis Corp to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in IsoPlexis Stock

If you are still planning to invest in IsoPlexis Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoPlexis Corp's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account